We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The World Health Organization has announced the current outbreak of mpox in African countries is a Public Health Emergency of International Concern (PHEIC) with potential to spread to other countries in and outside Africa.
The Africa Centres for Disease Control and Prevention reports 13 African countries have recorded cases in the latest update of 9 August 2024.
Countries affected are:
Burundi: 225 cases
Cameroon: 35 cases (2 deaths)
Central African Republic: 258 cases
Congo: 169 cases (1 death)
Cote d'Ivoire: 2 cases
Democratic Republic of Congo: 16 789 cases (511 deaths)
Ghana: 4 cases
Liberia: 5 cases
Kenya: 1 case
Nigeria: 24 cases
Rwanda: 2 cases
South Africa: 24 cases (3 deaths)
Uganda: 2 cases
Mpox is a zoonotic infection that is rarely seen in travellers arriving from African countries.
Transmission between people occurs through close skin to skin contact (including during sexual contact), or through droplet spread during close contact with a person infected with mpox.
Symptoms in people commence with fever, a flu-like illness and swollen glands followed by the development of a blistering skin rash, resembling chickenpox.
Travellers should:
Travellers to any destination who may be sexually active during travel (including GBMSM) should:
Travellers should be advised to seek medical help during, or for 21 days after travel if they develop symptoms of mpox and have:
While a vaccine specifically against mpox is not available, the smallpox vaccine provides some protection.
For further information see Mpox, Sexual Health Risks and LGBT travellers
Advice to travellers will be updated as appropriate.